Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
May 10 04:00PM ET
23.32
Dollar change
-0.08
Percentage change
-0.34
%
Index- P/E- EPS (ttm)-0.26 Insider Own0.57% Shs Outstand124.34M Perf Week1.35%
Market Cap2.90B Forward P/E- EPS next Y-0.06 Insider Trans0.00% Shs Float123.64M Perf Month1.26%
Income-31.63M PEG- EPS next Q-0.15 Inst Own30.68% Short Float1.99% Perf Quarter-3.72%
Sales170.26M P/S17.03 EPS this Y14.29% Inst Trans-10.04% Short Ratio4.87 Perf Half Y-6.53%
Book/sh4.04 P/B5.77 EPS next Y73.55% ROA-5.87% Short Interest2.46M Perf Year-1.48%
Cash/sh0.97 P/C23.97 EPS next 5Y- ROE-6.93% 52W Range14.10 - 26.01 Perf YTD-7.28%
Dividend Est.- P/FCF- EPS past 5Y-38.44% ROI-6.02% 52W High-10.34% Beta0.50
Dividend TTM- Quick Ratio3.55 Sales past 5Y43.40% Gross Margin67.52% 52W Low65.39% ATR (14)0.43
Dividend Ex-Date- Current Ratio4.75 EPS Y/Y TTM-137.86% Oper. Margin-29.25% RSI (14)54.69 Volatility1.30% 2.09%
Employees707 Debt/Eq0.05 Sales Y/Y TTM22.12% Profit Margin-18.58% Recom3.00 Target Price26.00
Option/ShortYes / Yes LT Debt/Eq0.05 EPS Q/Q-235.02% Payout- Rel Volume0.70 Prev Close23.40
Sales Surprise-23.71% EPS Surprise-140.00% Sales Q/Q19.45% EarningsMar 25 BMO Avg Volume504.25K Price23.32
SMA202.38% SMA500.26% SMA2006.72% Trades Volume353,117 Change-0.34%
Date Action Analyst Rating Change Price Target Change
Jan-05-23Initiated Scotiabank Sector Outperform $27
Dec-14-22Initiated Canaccord Genuity Buy $28
Apr-19-21Initiated SVB Leerink Outperform $50
Apr-19-21Initiated Morgan Stanley Equal-Weight
Apr-19-21Initiated Goldman Neutral $42
Apr-19-21Initiated BTIG Research Buy $44
May-10-24 08:15AM
07:10AM
Apr-19-24 04:05PM
Apr-02-24 08:00AM
Mar-25-24 08:00AM
08:00AM Loading…
08:00AM
Mar-15-24 08:00AM
Mar-08-24 08:00AM
Feb-06-24 08:43AM
Feb-02-24 06:19AM
Dec-30-23 09:30AM
Nov-15-23 07:00AM
Nov-14-23 03:57PM
Nov-08-23 09:58AM
Nov-05-23 08:00PM
05:20AM Loading…
Nov-03-23 05:20AM
Nov-02-23 10:00AM
Oct-31-23 08:43AM
Oct-25-23 11:26PM
02:00PM
Oct-18-23 09:52AM
09:44AM
Oct-17-23 05:19PM
11:29AM
09:02AM
08:52AM
08:49AM
08:19AM
Oct-05-23 04:25PM
Sep-19-23 03:00AM
11:00AM Loading…
Sep-12-23 11:00AM
Aug-29-23 08:00AM
Aug-09-23 08:50AM
07:00AM
Aug-08-23 08:00AM
Jul-26-23 10:52AM
Jul-25-23 09:55AM
Jul-13-23 08:00AM
Jul-12-23 04:01PM
09:00AM
Jun-28-23 08:00AM
Jun-09-23 09:05AM
May-25-23 08:00AM
May-22-23 07:57AM
May-11-23 08:45AM
07:00AM
May-05-23 10:00AM
Apr-24-23 12:00PM
Apr-17-23 04:05PM
Apr-13-23 08:00AM
Apr-06-23 06:14AM
Apr-05-23 05:22AM
Apr-04-23 11:16AM
Mar-29-23 08:00AM
Mar-27-23 07:30AM
Mar-21-23 08:00AM
Mar-20-23 03:15PM
Mar-15-23 04:05PM
Mar-06-23 08:00AM
Feb-28-23 08:00AM
Feb-22-23 12:02AM
Feb-21-23 08:25AM
07:00AM
Feb-16-23 09:43AM
Feb-06-23 10:00AM
06:30AM
Jan-18-23 11:07PM
04:14PM
Jan-09-23 08:00AM
Dec-31-22 07:20AM
Dec-29-22 08:00AM
Dec-27-22 09:04AM
Dec-14-22 08:00AM
Dec-09-22 09:18AM
Nov-29-22 09:40AM
Nov-18-22 08:39AM
Nov-17-22 08:00AM
Nov-14-22 08:00AM
Nov-12-22 07:52AM
Nov-10-22 08:15AM
07:00AM
Nov-09-22 06:25PM
Nov-03-22 08:00AM
Nov-01-22 08:00AM
Oct-24-22 08:00AM
Oct-18-22 12:00PM
Oct-13-22 08:00AM
Oct-12-22 07:58AM
Oct-11-22 02:10PM
Sep-20-22 04:05PM
08:50AM
Sep-15-22 04:05PM
Sep-09-22 09:39AM
Aug-31-22 08:00AM
Aug-30-22 08:00AM
Aug-11-22 08:25AM
08:00AM
07:00AM
Jul-14-22 08:00AM
Jun-28-22 08:00AM
Olink Holding AB engages in the provision of accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. It operates through the following segments: Kit, Service, and All Other Segments. The company was founded on December 13, 2018, and is headquartered in Uppsala, Sweden.